Estrella Immunopharma Warrant
ESLAW
9 hedge funds and large institutions have $354K invested in Estrella Immunopharma Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
13% more capital inflows, than outflows
Capital inflows: $2.69K | Capital outflows: $2.37K
8.52% less ownership
Funds ownership: 32.18% → 23.66% (-8.5%)
25% less funds holding
Funds holding: 12 → 9 (-3)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Robertson Stephens Wealth Management
San Francisco,
California
|
+$2.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1.46K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$728 |
| 3 |
Wolverine Asset Management
Chicago,
Illinois
|
-$113 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$67 |
ESLAW Hedge Fund Activity: Q4 2025 in Review
9 of the 8,302 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q4 2025, worth a combined $354K — up 44% from $245K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ESLAW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Robertson Stephens Wealth Management, opening a new position worth an estimated $2.69K. The largest seller was Toronto Dominion Bank, cutting an estimated $1.46K.
- 9 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q4 2025, down from 12 in Q3 2025.
- Funds reported $354K of Estrella Immunopharma Warrant stock for Q4 2025, up 44% quarter-over-quarter.
- 1 fund opened new Estrella Immunopharma Warrant positions in Q4 2025 and 3 closed out, a net change of -2 holders.
- The largest Estrella Immunopharma Warrant buyer in Q4 2025 was Robertson Stephens Wealth Management, an estimated $2.69K added.
- The largest Estrella Immunopharma Warrant seller in Q4 2025 was Toronto Dominion Bank, an estimated $1.46K sold.
Based on aggregated 13F filings for Q4 2025.